Abbott (ABT)

• Market cap: $225B
• 1 day: -1.43%
• 5 days: 0.11%
• 1 month: 2.07%
• 3 months: 5.37%
• 6 months: 10.96%
• Year to date: 14.46%
• 1 year: 20.68%
• 5 years: 38.22%
• 10 years: 167.93%
• Sector: Healthcare
• Industry: Medical Devices

About: Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Employees: 114,000

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

188% more first-time investments, than exits

New positions opened: 302 | Existing positions closed: 105

25% more call options, than puts

Call options by funds: $1.25B | Put options by funds: $999M

13% more funds holding in top 10

Funds holding in top 10: 63 [Q3] → 71 (+8) [Q4]

5% more capital invested

Capital invested by funds: $147B [Q3] → $155B (+$7.72B) [Q4]

5% more funds holding

Funds holding: 2,855 [Q3] → 2,991 (+136) [Q4]

3.21% more ownership

Funds ownership: 74.27% [Q3] → 77.48% (+3.21%) [Q4]

3% less repeat investments, than reductions

Existing positions increased: 1,109 | Existing positions reduced: 1,147

Research analyst outlook

11 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $127 2% downside
• Avg. target: $146 13% upside
• High target: $160 23% upside

11 analyst ratings

• positive: 9 82%
• neutral: 2 18%
• negative: 0 0%

Raymond James Jayson Bedford 39% 1-year accuracy 11 / 28 met price target	9% upside $142	Outperform Maintained	17 Apr 2025
Piper Sandler Adam Maeder 33% 1-year accuracy 4 / 12 met price target	12% upside $145	Overweight Reiterated	17 Apr 2025
RBC Capital Shagun Singh 34% 1-year accuracy 23 / 67 met price target	12% upside $145	Outperform Maintained	17 Apr 2025
Wells Fargo Lawrence Biegelsen 25% 1-year accuracy 1 / 4 met price target	13% upside $147	Overweight Maintained	17 Apr 2025
Morgan Stanley David Lewis 0 / 0 met price target	2% downside $127	Equal-Weight Maintained	17 Apr 2025